FMP

FMP

Enter

HSTO - Histogen Inc.

photo-url-https://images.financialmodelingprep.com/symbol/HSTO.png

Histogen Inc.

HSTO

NASDAQ

Inactive Equity

Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.

0.02 USD

0 (0%)

About

ceo

Ms. Susan A. Knudson

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.

CIK

0001383701

ISIN

US43358Y2028

CUSIP

43358Y103

Address

10655 Sorrento Valley Road

Phone

858 526 3100

Country

US

Employee

7

IPO Date

Jul 25, 2013

Key Executives

Name

Title

Pay

Year Born

Ms. Susan A. Knudson

President, Chief Executive Officer, Chie...

653.2k

1964

As of December 31, 2024, the total employee count stands at 7, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep